Ainvest Option Flow Digest - 2026-05-20: $68M Across 9 Names — Bear Stack on ACN/NOW Into June Earnings, EME Twin Bull Spreads, an RKT Bull Spread, and a Biotech Binary Risk-Reversal

A calm read of where large options money went today — and, just as important, what it actually means. The dollar headline is bear-tilted ($31M+ across ACN and NOW long puts), but the structures matter: position sizing and patience beat chasing any single print below.

The Quick Read

We tracked roughly $68M of notable options premium across 9 tickers. Today's tape leans bearish/defensive on the high-dollar end (ACN puts, NOW puts), with two defined-risk bullish call spreads (EME and a smaller one on RKT) and a biotech binary in the middle. The honest version:

• The bear-stack into Accenture earnings: ACN — a $13.1M institutional put sweep at 11:06:25 across four legs (three at the Jan'27 $165 strike, one at the $125), all clearly fresh opens. Lands squarely ahead of confirmed June 18 Q3 earnings, against a backdrop of federal-contract cuts and Gen-AI consulting displacement fears.
• The biggest bear ticket of the day: NOW — a single 12:38:42 sweep totaling ≈$18.3M of Jan'27 puts across the $92 and $70 strikes on ServiceNow (post-split spot ≈$101.69). DOGE federal-contract risk and the pending Armis acquisition margin drag are the live overhangs.
• The defined-risk bullish bet: EME — TWO bull call spreads on EMCOR (≈$20M gross, but as spreads the net debit is small): BTO $580/STO $600 at 09:48, then BTO $620/STO $660 at 09:56. The ⏳ open/close on the BTO legs is not yet OI-confirmed — could include rolls — and resolves at the May 21 pre-market snapshot.
• The cleanest bullish print: CSCO — $5.9M in March'27 $130 calls, ≈12% OTM. Cisco just printed a record Q3, hit an all-time high two days ago, and saw six analyst PT hikes — the long-call thesis is consensus, but well-positioned for Aug 12 earnings.
• A smaller bull call spread on a 30%+ rally bet: RKT — $2.9M gross / ≈$0.7M net debit in a Sep'18 $17/$18 bull call spread on Rocket Companies (spot $13.49). The position needs a ≈26% rally to start paying — sized around Q2 earnings (Jul 30) and the mortgage-rate path. The SELL leg's open/close is not yet OI-confirmed.
• A biotech binary in a wrapper: SLS — a $2.6M bearish risk-reversal (sell Jan'27 $15 calls / buy Oct'26 $6 puts) on a small-cap immuno-oncology name 78 of 80 OS events into its pivotal REGAL Phase 3 trial. Topline expected within weeks.
• A lottery ticket on Intel: INTC — $2.2M for July 17 $195 calls, ≈65-77% OTM after Intel's 5× rally from $20 to $110 since August 2025. Critical: these expire SIX DAYS before earnings (Jul 23) — so it's pure pre-earnings momentum speculation, not an earnings play.
• Patient China bull bet: ASHR — $1.4M in Oct'26 $38 calls on the CSI 300 A-shares ETF (≈7.5% OTM). Note: the Nov 10 tariff truce expiry is just after the option expires, so the position avoids that binary rather than playing it.
• Quiet bearish: ZETA — $1.1M of Jan'27 $17.50 puts just under spot, hedging or fading the AI-marketing rally after the Marigold acquisition and OpenAI Athena GA.

A large print shows what one participant did with size — not what will happen. The bear-side dollars here (ACN + NOW ≈ $31M of puts) are real, but each is well-explained by a known overhang (DOGE federal cuts hit both names). Read these as starting points for your own work, size so a total loss of the premium wouldn't hurt, and never chase a print after the move already happened.

✅ Updated May 21, 2026 — both open/close ambiguities resolved. The next-session OPRA OI snapshot is in. RKT is a confirmed bull call spread — both legs opened fresh (the $18 SELL leg was a fresh short/STO, +13,317 OI; the $17 long opened +20,019). EME is mixed — the $580 long (+200) and $660 short (+400) opened cleanly, but the $620 leg's OI fell −304 (net closing) and $600 was flat, so it was a repositioning/roll within EMCOR's call structure, not two textbook fresh bull call spreads. Each per-ticker analysis carries the full OI table and a Last-updated stamp.

Today's Flow at a Glance

Premium figures match each detailed analysis. Where a trade is a spread (EME, net debit small) or a risk-reversal (SLS, net debit small), the table says so — gross dollars exaggerate the at-risk capital.

The Whale Lineup

1. 🐋 EME — Two Bull Call Spreads, ≈$20M Gross / ≈$0.9M Net Debit

See the defined-risk twin bull spreads on EMCOR's AI buildout →

• What's happening: Eight legs forming two distinct bull call spreads on Dec 18 2026 expiry — BTO $580 / STO $600 at 09:48:18, and BTO $620 / STO $660 at 09:56:42, all deep ITM relative to spot ≈$859. The gross dollar number is large but most of that is intrinsic; the net debit per spread is roughly the strike-spacing minus intrinsic, far smaller than the headline.
• The catalyst: EMCOR's data-center construction backlog is the dominant story (Q1 RPO +33% YoY, ATH May 6); Q2 earnings ≈July 30 is the major binary inside the Dec expiry.
• ✅ Resolved (mixed): the May 21 OI showed this was NOT two clean fresh bull call spreads. The $580 long (+200) and $660 short (+400) opened cleanly, but the $620 leg's OI fell −304 (net closing) and $600 was flat. The most coherent read is a repositioning/roll within EMCOR's call structure — still broadly bullish, but not two textbook new debit spreads.

2. 🐻 NOW — $18.3M Bearish Put Stack Into July Earnings

Decode the $18.3M ServiceNow put sweep — DOGE + Armis overhang →

• What's happening: Seven fills at 12:38:42, all BUY PUT, mostly the Jan'27 $92 strike (≈30,000 contracts) plus the $70 strike (≈11,000). Spot $101.69 is the post-split price (NOW did a 5-for-1 split in Dec 2025) — so the $92 puts are ≈9% OTM and the $70 puts are ≈31% OTM. Defined-risk bearish — max loss = premium.
• The catalyst: Q2 earnings ≈July 29, inside the expiry. The bear thesis is well-articulated: DOGE-driven federal contraction (one federal channel partner = 19% of A/R), the pending $7.75B Armis acquisition margin drag, and recent analyst PT cuts (UBS $170→$100, KeyBanc Sell at $85). NOW has already fallen ≈57% from its peak.

3. 🐻 ACN — $13.1M Put Sweep Into Confirmed June 18 Earnings

See the four-leg bearish bet on Accenture into Q3 →

• What's happening: Four BUY PUT prints at the same 11:06:25 timestamp — three at Jan'27 $165 (≈5,273 contracts combined, ≈$11.1M) and one at $125 (2,806 contracts, $2M). Volume far above existing OI of 150 = clearly fresh opens.
• The catalyst: Confirmed Q3 FY26 earnings June 18, 2026 (before market open), well inside the put expiry. Backdrop: ACN fell -7.15% on May 13 on renewed federal-contract / Gen-AI displacement headlines; analyst PT cascade (Citi $266→$215, Mizuho $309→$280). The whale is sized for the June print to disappoint and the multi-quarter consulting deceleration to continue.

4. 🐋 CSCO — $5.9M Bullish Call on AI Networking After a Record Q3

See the bullish March'27 Cisco call on a name at all-time highs →

• What's happening: $5.9M into Mar 19 2027 $130 calls (spot ≈$116, ≈12% OTM, Vol/OI ≈4 = clearly fresh). A measured medium-dated bull bet, not a moonshot.
• The catalyst: Cisco just printed a record Q3 on May 13 (revenue $15.8B +12% YoY) and raised the FY26 AI-orders guide from $5B to $9B (an 80% jump). Six analysts hiked PTs (HSBC $137, Morgan Stanley $120, Evercore $150). Stock hit ATH $118.88 on May 18. Cisco Live runs June 2-12; next earnings Aug 12 is the next major catalyst inside expiry.

5. 🐋 RKT — $2.9M Bull Call Spread Needing a 26%+ Rally

See the defined-risk Rocket Companies setup into Q2 earnings →

• What's happening: Two same-second legs at 14:45:20 on Sep 18 2026 expiry — BUY $17 calls (20,000 contracts, $1.8M, Vol/OI ≈3.77 = clearly fresh) and SELL $18 calls (15,000 contracts, $1.1M, Vol/OI ≈0.94 = ambiguous). Net debit per spread ≈$0.20/contract; gross premium ≈$2.9M with ≈$0.7M at net risk. Sizes don't match exactly (20K vs 15K), so strictly this is ≈15K of bull call spread + ≈5K of standalone $17 long call.
• The catalyst: Q2 earnings confirmed Jul 30, 2026 (inside expiry). Q1 was a +127% YoY revenue beat post the Mr. Cooper ($14.2B, closed Oct 2025) and Redfin ($1.75B, closed Jul 2025) acquisitions; analyst PTs cluster $18-21 (BofA $18, KBW $21). The position needs RKT above $17 by Sep 18 to start paying — a ≈26% rally from $13.49 spot.
• ✅ Resolved: the May 21 OI confirms the bull call spread — the SELL $18 leg opened a fresh short (+13,317 OI, STO not a close) and the $17 long opened (+20,019). Exactly as classified: a defined-risk bullish bet needing RKT above $17 by Sep 18.

6. 🎯 SLS — $2.6M Risk-Reversal Ahead of a Pivotal AML Phase 3 Readout

See the binary risk-reversal on SELLAS's REGAL trial →

• What's happening: Same-second paired structure: sell Jan'27 $15 calls ($1.4M credit, ≈76% OTM at $8.52 spot) and buy Oct'26 $6 puts ($1.2M debit, ≈30% OTM). Net debit ≈$0.2M. The shape is a bearish skew — cap upside cheaply (the $15 calls are far OTM), pay for near-term downside protection.
• The catalyst: SELLAS's REGAL Phase 3 GPS-in-AML overall-survival trial sat at 78 of 80 required OS events as of May 11, with CEO commentary that data could arrive "within weeks." That's the binary the structure trades around. A miss historically produces 60–80% single-session drawdowns on small-cap biotech. Defined-skew, but binary — size accordingly.

7. 🐋 INTC — $2.2M Lottery That Expires Before Earnings

See the high-leverage Intel call expiring six days before the print →

• What's happening: $2.2M into July 17 $195 calls with spot ≈$118 — that's a deeply out-of-the-money strike (≈65-77% OTM) on a name that has already 5×'d from August 2025 lows of ≈$20. Vol/OI ≈5.9 = clearly fresh.
• The catalyst (carefully): Intel Q2 earnings is confirmed July 23 — six days AFTER the July 17 expiry. So this is not an earnings play; it's a bet on continued momentum or pre-earnings news flow (Computex previews, Clearwater Forest 18A launch, Apple PDK news, Jaguar Shores reveal) inside the next 8 weeks. The base case is a total premium loss. This is lottery-ticket positioning — premium fully at risk.

8. 🐋 ASHR — $1.4M Patient China A-Shares Bull Bet

See the China onshore A-shares bull setup →

• What's happening: $1.4M of Oct 16 2026 $38 calls (spot $35.36, ≈7.5% OTM, Vol/OI ≈101 = clearly fresh). A medium-dated directional bet on CSI 300 onshore A-shares (distinct from FXI which is Hong-Kong-listed H-shares).
• The catalyst: CSI 300 at a 4-year high after the Trump-Xi tariff truce; PBOC May easing package; Q2 GDP ≈Jul 15; late-July Politburo. Notable timing: the Nov 10 tariff-truce expiry sits just outside the Oct 16 option expiry — so the position rides the truce window but does not take on the tariff-cliff binary.

9. 🐻 ZETA — $1.1M Bearish Put Block Just Under Spot

See the bearish put on the AI-marketing rally →

• What's happening: $1.1M of Jan'27 $17.50 puts with spot $18.47 (≈5% OTM, Vol/OI ≈6.5 = clearly fresh). Long-dated near-the-money bearish/hedge.
• The catalyst: Q1 2026 was a beat-and-raise (+50% YoY), Athena AI-marketing agent went GA, Marigold acquisition closed Nov 2025. But Zeta has prior short-attack history (Culper Research); the put could be a hedge against a re-emergence, integration slippage, or generic growth-software multiple compression. Next earnings Aug 5, inside expiry.

Read It By Your Style

Not recommendations — just how disciplined approaches might think about today's tape. Risk control first.

• 🎲 YOLO / event trader: INTC is the closest thing to a lottery on the tape — short-dated, deep-OTM, expires before earnings, defined-risk premium ≤1%. SLS is binary clinical — REGAL data inside weeks, with potential 60-80% gaps on miss; only if you understand small-cap biotech outcome distributions. Both can go to zero in days.
• 📈 Swing trader: CSCO is the cleanest swing setup — fresh ATH, six analyst upgrades, Q3 beat, expiry past Aug 12 earnings. A defined-risk bull call spread expresses it without chasing. EME's spreads are already structurally defined-risk; if you replicate, study the bull-call-spread math (max profit = spread width − net debit).
• 💵 Premium collector: Today is light on clean premium-sell setups. SLS is the closest, but only as part of the risk-reversal — selling naked deep-OTM calls into a binary trial is not retail-appropriate. The bigger lesson today: when you see "deep-ITM call SELL" or "long put with Vol/OI < 1," ask whether it's a close (profit-taking) before assuming it's a fresh short — the prior session's MAR resolution drove that home.
• 🌱 Just getting started: Two lessons today. First, structure ≠ headline dollar: EME's "$20M" looks huge but as bull call spreads the at-risk capital is a fraction. Second, expiry vs. catalyst date matters: INTC's calls expire BEFORE earnings, which makes them a momentum bet, not an earnings bet — read each ticker's "catalyst inside expiry?" line before you act. Watch, don't trade, the SLS and INTC binaries.

Upcoming Catalysts — Event vs. the Option That Plays It

Catalyst and the option expiration positioned for it are listed separately so the timing is unambiguous:

The nearest hard binary is SLS REGAL (weeks away); the most calendar-dense catalyst is ACN's June 18 earnings — that's the event the largest non-spread bear ticket on the tape is positioned around. EME's open/close resolves tomorrow pre-market.

The Bottom Line

Today is a lesson in reading flow correctly rather than loudly. The dollar ranking — EME, NOW, ACN — hides that #1 (EME) is a defined-risk bull spread, #2 (NOW) is a textbook bearish put stack into a known overhang, and #3 (ACN) is a tightly-timed earnings bet. The genuine clean signals today are: ACN's bearish put sweep into a confirmed earnings date, NOW's large but well-explained bear stack, and CSCO's measured bullish setup after a record quarter. SLS and INTC are binaries — treat as positions, not as the rest of the book.

Large prints are information, not instructions. Size small, prefer defined risk, and let the catalyst — not the headline number — do the work.

Full per-ticker analyses are linked in each section above. Options involve substantial risk and are not suitable for every investor. This newsletter is informational and not investment advice. Past performance of any strategy does not predict future results.

Ainvest Option Flow Digest — May 20, 2026 | Last updated: May 21, 2026 (OI resolution applied to EME + RKT)